Bone Drug Fails to Stop Breast Cancer

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=Z-WFWxmYzs0

SAN ANTONIO -- Women with stage II/III breast cancer derived no survival benefit when the bisphosphonate zoledronic acid (Zometa) was added to adjuvant chemotherapy and hormonal therapy, results of a large multicenter study showed. • Medpage Today: http://medpagetoday.com • Online CME - Continuing medical education: http://www.medpagetoday.com/cme/ • Latest medical news: http://www.medpagetoday.com/latest/ • The MedPage Today app: • iOS: https://goo.gl/JKrkHq • Android: https://play.google.com/store/apps/de... • MedPage Today Youtube Channel: / medpagetoday • Medpage Today on Facebook: / medpagetoday

#############################

New on site